Aa
Here;s some interesting info I came across
Please do not take my word but do your own research. I read so much that I can't possibly keep all the links or even remember where I saw it. Somethings can't be linked unless you are a member.
I read something interesting whether true or not only your doctor knows.
If you have the antibodies to Hep B which a lot of people will find they do. If you have to have chemotherapy it can reactivate the hep B. You doctor has to know to test you for hep B to take whatever the proper precautions recommended. Wonder how many doctors know this?.
I read something interesting whether true or not only your doctor knows.
If you have the antibodies to Hep B which a lot of people will find they do. If you have to have chemotherapy it can reactivate the hep B. You doctor has to know to test you for hep B to take whatever the proper precautions recommended. Wonder how many doctors know this?.
"....Chemotherapy and its related immunosuppression can cause a reactivation of HBV – "a potentially fatal and preventable disease," said Emmy Ludwig, MD, from Memorial Sloan-Kettering Cancer Center in New York City.
"Reactivation may complicate cancer therapy," said Dr. Ludwig, explaining that delays in treatment can result.
Testing allows infected patients — those with chronic infection or past exposure — to be treated with prophylactic antiviral oral therapy, which is an "extremely effective" means of preventing reactivation, she said. Dr. Ludwig also told the NCCN audience that 5% to 40% of reactivation cases will die of liver failure.
Currently, cancer patients treated with rituximab are routinely screened for HBV, said Dr. Ludwig. In 2004, the US Food and Drug Administration issued a warning that there was a risk for HBV-reactivation-related fatal fulminant hepatitis with rituximab.
However, the need to screen for HBV is often associated only with "high-risk" groups, said Dr. Ludwig, especially natives of Asia. But "profiling patients by country of birth misses patients — about half of them," she said.
Furthermore, she said that the HBV problem is "enormous" and that an estimated one third of the world has been "exposed" to HBV, meaning that they have a core antibody (HBcAb+), and that about 350 million people have chronic infection, meaning that they have a surface antigen (HBsAg+).
In the United States, an estimated 15 million people (5% of population) have been exposed and about 1 million have chronic infection.
Interestingly, the NCCN does not recommend universal testing for patients undergoing chemotherapy....."
Test All Chemo Patients for Hepatitis B, Says NCCN Presenter
March 17, 2011 (Hollywood, Florida)
http://www.medscape.com/viewarticle/739169
"Reactivation may complicate cancer therapy," said Dr. Ludwig, explaining that delays in treatment can result.
Testing allows infected patients — those with chronic infection or past exposure — to be treated with prophylactic antiviral oral therapy, which is an "extremely effective" means of preventing reactivation, she said. Dr. Ludwig also told the NCCN audience that 5% to 40% of reactivation cases will die of liver failure.
Currently, cancer patients treated with rituximab are routinely screened for HBV, said Dr. Ludwig. In 2004, the US Food and Drug Administration issued a warning that there was a risk for HBV-reactivation-related fatal fulminant hepatitis with rituximab.
However, the need to screen for HBV is often associated only with "high-risk" groups, said Dr. Ludwig, especially natives of Asia. But "profiling patients by country of birth misses patients — about half of them," she said.
Furthermore, she said that the HBV problem is "enormous" and that an estimated one third of the world has been "exposed" to HBV, meaning that they have a core antibody (HBcAb+), and that about 350 million people have chronic infection, meaning that they have a surface antigen (HBsAg+).
In the United States, an estimated 15 million people (5% of population) have been exposed and about 1 million have chronic infection.
Interestingly, the NCCN does not recommend universal testing for patients undergoing chemotherapy....."
Test All Chemo Patients for Hepatitis B, Says NCCN Presenter
March 17, 2011 (Hollywood, Florida)
http://www.medscape.com/viewarticle/739169
If you've never been exposed to hep b nothing to worry about. I was told in group testing for hep b when you have a small viral load that shows you've been exposed is normal practice when you have chronic hep c.
Don't know if that is the same as being exposed and clearing. As my understanding with hep a is you can get it again if you cleared and are exposed again.Vacines I believe are different, but I'm not an expert. I do know my hepotolotgist has tested my hep B viral load and I wondered why he would do that, It's my understanding it can come back when you have hep c but don't thing the vaccine is the same. Ask you doctor.
This is very interesting. It scares me sometimes to think of all the interactions there are between medications, foods supplements, who can keep track?
Thanks for sharing
Dee
Thanks for sharing
Dee
Have an Answer?
You are reading content posted in the Hepatitis Social Community
A list of national and international resources and hotlines to help connect you to needed health and medical services.
Herpes sores blister, then burst, scab and heal.
Herpes spreads by oral, vaginal and anal sex.
STIs are the most common cause of genital sores.
Condoms are the most effective way to prevent HIV and STDs.
PrEP is used by people with high risk to prevent HIV infection.
